Microfluidic formation of magnetised microgels encapsulating live cells, droplet networks, and drug-loaded nanoparticles as multi-responsive biomateri

Scientists are building artificial cells that can swim, reshape themselves, and deliver drugs on command. This project addresses a fundamental gap: natural cells can sense their environment, move, and change shape, but synthetic materials rarely combine all these abilities. Current drug delivery systems, for example, release medicine passively without responding to the body’s needs. The researchers aim to create soft, magnetised microgels—tiny gel particles—that encapsulate living cells, droplet networks, and drug-loaded nanoparticles. Using droplet microfluidics, they will precisely assemble these components into reconfigurable “artificial cells” that convert environmental energy into motion and structural change. If successful, these multi-responsive materials could transform tissue engineering and targeted drug delivery. A patient might receive an injection of microgels that navigate to a tumour, release chemotherapy only when triggered, and then reconfigure to support tissue repair. The work also advances the emerging field of “Engineered Living Materials,” where synthetic and biological components work together as swarm-like microrobots. This is primarily fundamental science—understanding how to build soft machines that mimic biological functions. But similar curiosity-driven work on microfluidics and responsive materials has already spawned lab-on-a-chip diagnostics and smart drug carriers. Deeper knowledge here could unlock medical treatments that adapt to the body in real time.